From: Mineralocorticoid receptor antagonists in dialysis patients
Effects of aldosterone | Myocardial fibrosis and remodeling |
Vascular injury and fibrosis | |
Reduced vascular compliance | |
Impaired baroreceptor function | |
Endothelial dysfunction | |
Catecholamine potentiation | |
Ventricular arrhythmias | |
Progressive renal disease | |
K+ and Mg2+ loss | |
Sodium reabsorption and water retention | |
Prothrombotic effects (Increasing PAI-1) | |
Aldosterone-associated disorders | Hypertension |
Heart failure and cardiac hypertrophy | |
Stroke | |
Ischemia and arteriosclerosis | |
End-stage renal disease | |
Peritoneal fibrosis |